The stock of Nu Skin Enterprises, Inc. (NYSE:NUS) is a huge mover today! About 1.78 million shares traded hands or 147.05% up from the average. Nu Skin Enterprises, Inc. (NYSE:NUS) has risen 59.42% since April 4, 2016 and is uptrending. It has outperformed by 58.33% the S&P500.
The move comes after 6 months negative chart setup for the $2.85 billion company. It was reported on Nov, 4 by Barchart.com. We have $49.28 PT which if reached, will make NYSE:NUS worth $228.00M less.
Nu Skin Enterprises, Inc. (NYSE:NUS) Ratings Coverage
Out of 9 analysts covering Nu Skin (NYSE:NUS), 3 rate it a “Buy”, 1 “Sell”, while 5 “Hold”. This means 33% are positive. Nu Skin has been the topic of 24 analyst reports since July 21, 2015 according to StockzIntelligence Inc. Zacks upgraded the shares of NUS in a report on Thursday, August 13 to “Sell” rating. Citigroup maintained the shares of NUS in a report on Tuesday, April 19 with “Buy” rating. The stock of Nu Skin Enterprises, Inc. (NYSE:NUS) earned “Hold” rating by Jefferies on Friday, June 3. Stifel Nicolaus downgraded the stock to “Sell” rating in Wednesday, October 7 report. The firm earned “Hold” rating on Wednesday, October 7 by Canaccord Genuity. The firm has “Hold” rating by Canaccord Genuity given on Thursday, July 30. The firm earned “Neutral” rating on Tuesday, July 21 by Sterne Agee CRT. Jefferies maintained Nu Skin Enterprises, Inc. (NYSE:NUS) on Thursday, September 22 with “Hold” rating. The firm has “Buy” rating given on Friday, August 7 by Deutsche Bank. The stock of Nu Skin Enterprises, Inc. (NYSE:NUS) earned “Buy” rating by Citigroup on Wednesday, September 21.
According to Zacks Investment Research, “Nu Skin is a premier anti-aging company. The company’s anti-aging products feature the ageLOC line of products including ageLOC Tru Face Essence Ultra firming serum, the ageLOC TR90 weight management and body shaping system, ageLOC R2 nutritional supplement, and ageLOC Transformation daily skin care system.”
Insitutional Activity: The institutional sentiment increased to 1.07 in 2016 Q2. Its up 0.03, from 1.04 in 2016Q1. The ratio improved, as 30 funds sold all Nu Skin Enterprises, Inc. shares owned while 60 reduced positions. 36 funds bought stakes while 60 increased positions. They now own 40.71 million shares or 5.55% less from 43.10 million shares in 2016Q1.
Ahl Partners Ltd Liability Partnership has invested 0.21% of its portfolio in Nu Skin Enterprises, Inc. (NYSE:NUS). Prudential, a New Jersey-based fund reported 7,790 shares. Boston Prns, a Massachusetts-based fund reported 485,227 shares. Miles Cap has invested 0.65% of its portfolio in Nu Skin Enterprises, Inc. (NYSE:NUS). First Quadrant Lp Ca last reported 23,323 shares in the company. Engineers Gate Manager Limited Partnership last reported 0.21% of its portfolio in the stock. International has 29,459 shares for 0% of their US portfolio. Nuveen Asset Mngmt Limited Liability, a Illinois-based fund reported 223,129 shares. Quinn Opportunity Partners Llc owns 16,000 shares or 0.29% of their US portfolio. Winfield Associate holds 20 shares or 0% of its portfolio. Smith Thomas W reported 219,350 shares or 14.57% of all its holdings. Palisade Mngmt Lc Nj holds 0.04% of its portfolio in Nu Skin Enterprises, Inc. (NYSE:NUS) for 23,750 shares. Ingalls And Snyder Limited has 54,290 shares for 0.15% of their US portfolio. Gradient Investments Limited Liability Corporation accumulated 0% or 406 shares. Price T Rowe Assocs Md holds 126,805 shares or 0% of its portfolio.
Insider Transactions: Since September 22, 2016, the stock had 0 insider buys, and 2 insider sales for $5.68 million net activity. The insider LIPMAN ANDREW D sold $1.92M. 61,000 shares with value of $3.75 million were sold by LUND STEVEN on Wednesday, October 26.
More notable recent Nu Skin Enterprises, Inc. (NYSE:NUS) news were published by: Prnewswire.com which released: “Nu Skin Enterprises Announces Quarterly Dividend” on November 03, 2016, also Fool.com with their article: “Why Nu Skin Enterprises Inc. Stock Jumped 17% in June” published on July 07, 2016, Wsj.com published: “Nu Skin Raises $210 Million From Chinese Investors” on June 16, 2016. More interesting news about Nu Skin Enterprises, Inc. (NYSE:NUS) were released by: Fool.com and their article: “Why Nu Skin Enterprises Inc. Stock Rose Today” published on August 05, 2016 as well as Forbes.com‘s news article titled: “Ex-Dividend Reminder: Fortune Brands Home & Security, NU Skin Enterprises and …” with publication date: August 22, 2016.
NUS Company Profile
Nu Skin Enterprises, Inc., incorporated on September 4, 1996, is a global direct selling firm that develops and distributes personal care products and nutritional supplements, and a range of other services and products. The Firm offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Firm has activities in various geographic regions, including Greater China, North Asia, Americas, South Asia/Pacific, and Europe, the Middle East and Africa (EMEA). The Firm operates in the direct selling channel, primarily utilizing person-to-person marketing to promote and sell its products. The Firm offers Pharmanex nutritional supplements and Nu Skin personal care products under its ageLOC anti-aging brand. It also offers a limited number of other services and products, including household products and technology services.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.